TNFRSF10B, a Therapeutic Target for Oral Squamous Cell Carcinoma Through Integrated Bioinformatics and Preliminary Experiments
Technology in Cancer Research & Treatment · 2026-03 · 25
DOI: 10.1177/15330338261426318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 02.03.2026. Verfasst von Yingshun Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Hebei Eye Hospital, Xingtai, China. Hauptthemen laut MEDLINE: Computational Biology, Mouth Neoplasms, Carcinoma, Squamous Cell, Receptors, TNF-Related Apoptosis-Inducing Ligand. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Science Research Project of Hebei, Hebei Natural Science Foundation.
Abstract (Originalsprache)
Background
Tumor necrosis factor receptor superfamily member (10B TNFRSF10B), as a key apoptosis regulator of Oral Squamous Cell Carcinoma (OSCC), exerts a critical effect on its development.
Methods
Differentially expressed genes in OSCC (GSE25099) were screened first. Weighted gene co-expression network analysis identified gene modules, followed by Lasso regression and Cox modeling to pinpoint pivotal genes. Expression was validated in the Cancer Genome Atlas databases and in clinical samples. The Search Tool for the Retrieval of Interacting Genes/Proteins database was used to generate a protein–protein interaction (PPI) network, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses explored biological functions. Then, for in vitro assays, core gene-targeted siRNAs were introduced into SCC-4 and SCC-9 cell lines to mediate gene knockdown. Cell proliferation was quantified by the CCK-8 method, and apoptotic activity was assessed via flow cytometry, TUNEL staining, and Western blotting for apoptosis-associated proteins.
Results
Among the 10 core genes that were further screened, TNFRSF10B was most notably linked to unfavorable OSCC prognosis and showed strong diagnostic power. Additionally, its overexpression was associated with clinical stage, nodal metastasis, and chemoresistance. PPI and enrichment analyses revealed its role in extrinsic and necroptotic apoptosis. Moreover, the knockdown of TNFRSF10B suppressed viability and induced apoptosis by upregulating Bax, downregulating Bcl-2, and activating Caspase-3/PARP.
Conclusions
TNFRSF10B drives OSCC progression by impairing apoptosis. Its overexpression correlates with poor prognosis and represents a potential diagnostic and therapeutic target. Furthermore, targeting TNFRSF10B may restore apoptosis, thus making precision therapy achievable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Hebei Eye Hospital, Xingtai, China.
- Department of Stomatology, Affiliated Hospital of Hebei University, Baoding, China.
- Department of Oral Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Stomatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Yongle Qiu
Förderung
- Medical Science Research Project of Hebei
- Hebei Natural Science Foundation
Zitieren
APA
Yang, Y., Zhuang, Z., Hu, Y., Liu, J., Guo, J., Jin, L., & Qiu, Y. (2026). TNFRSF10B, a Therapeutic Target for Oral Squamous Cell Carcinoma Through Integrated Bioinformatics and Preliminary Experiments. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261426318
Vancouver
Yang Y, Zhuang Z, Hu Y, Liu J, Guo J, Jin L, et al. TNFRSF10B, a Therapeutic Target for Oral Squamous Cell Carcinoma Through Integrated Bioinformatics and Preliminary Experiments. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261426318
BibTeX
@article{Yang2026,
author = {Yang, Yingshun and Zhuang, Zhizheng and Hu, Yan and Liu, Jilun and Guo, Jie and Jin, Linyu and Qiu, Yongle},
title = {TNFRSF10B, a Therapeutic Target for Oral Squamous Cell Carcinoma Through Integrated Bioinformatics and Preliminary Experiments},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
volume = {25},
doi = {10.1177/15330338261426318}
}
EUVIMED